(Q45295821)

11 December 2017

title

Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting (English)

1 reference

Mycobacterium tuberculosis

11 December 2017

main subject

0 references

author name string

J Dou

1

1 reference

11 December 2017

Y Wang

2

1 reference

11 December 2017

F Yu

3

1 reference

11 December 2017

H Yang

4

1 reference

11 December 2017

J Wang

5

1 reference

11 December 2017

X He

6

1 reference

11 December 2017

W Xu

7

1 reference

11 December 2017

J Chen

8

1 reference

11 December 2017

K Hu

9

1 reference

11 December 2017

publication date

8 December 2011

1 reference

International Journal of Immunogenetics

11 December 2017

published in

1 reference

11 December 2017

volume

39

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

183-190

1 reference

Mycobacterium tuberculosis (Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated controls from TB patients

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing mycobacterial antigen 85A and interleukin-21 and Bacillus Galmette-Guérin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

DNA vaccines against mycobacterial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Tuberculosis: what we don't know can, and does, hurt us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Towards new tuberculosis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Bronchial epithelial cells in allergic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Macrophages are a significant source of type 1 cytokines during mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

A vital role for interleukin-21 in the control of a chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-313X.2011.01066.X

10.1111/J.1744-313X.2011.01066.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference